AI Proteins has raised $41.5 million in Series A financing, led by Mission BioCapital and Santé Ventures, to advance innovative de novo miniproteins as a new therapeutic modality.
Amount Raised
$41.5 Million
Round Type
Series A
BostonBiotechnologyArtificial IntelligenceInvestors
Description
AI Proteins, a biotech company, has closed a $41.5 million Series A financing round to accelerate its mission in developing new medicines using artificial intelligence. This round was led by Mission BioCapital along with Santé Ventures, and included participation from existing investors. The funds will enable the creation of transformative new therapeutics based on de novo miniproteins. These modular miniproteins are designed without evolutionary constraints to achieve better therapeutic control.
Quick answer
AI Proteins raised $41.5 Million in a Series A round, dated November 19, 2025. Investors: Lightchain Capital, Cobro Ventures, Mission BioCapital and Santé Ventures. AI Proteins is based in Boston, Massachusetts, United States.
- How much did AI Proteins raise?
- AI Proteins raised $41.5 Million in a Series A round on November 19, 2025.
- Who invested in AI Proteins?
- Lightchain Capital, Cobro Ventures, Mission BioCapital and Santé Ventures are named as investors in this round.
- What does AI Proteins do?
- AI Proteins is a Boston-based biotech company reimagining protein therapeutics through AI-enabled design and a high-throughput discovery platform.
- Where is AI Proteins based and how big is it?
- AI Proteins is based in Boston, Massachusetts, United States. Fundz records about 34 employees.
- Who are the decision-makers at AI Proteins?
- Fundz holds 1 contact at AI Proteins, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as AI Proteins that raised within 45 days of this round, from Fundz verified event records.
- DP Technology raised $114M (Series C) on December 24, 2025.
- Qureator raised $6.7M on December 23, 2025.
- Galatek raised $30M (Series A) on December 19, 2025.
- Edison Scientific raised $70M (Seed) on December 18, 2025.
- Novyte Materials raised $459K (Pre-Seed) on December 18, 2025.
- Arcreal raised $5.4M (Pre-Series A) on December 17, 2025.
Who to call at AI Proteins, and when
A new round usually means AI Proteins is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AI Proteins raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AI Proteins, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AI Proteins. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AI Proteins raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAI Proteins raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.